Well, there is this. But I don't much care for companies that crow about a dismissal on venue.
MorphoSys Wins Second Motion to Dismiss on CAT Winter II Patent Suit in San Diego Court
MARTINSRIED and MUNICH, Germany, Aug. 20 /PRNewswire/ -- MorphoSys AG (Neuer Markt: MOR), the German biotechnology company, announced today that a court in San Diego has granted its motion to dismiss a second attempt by Cambridge Antibody Technology Ltd. (CAT), together with The Medical Research Council, The Scripps Research Institute and Stratagene to bring a suit alleging infringement of their ``Winter II'' US patent (No. 6,248,516). In late June, the Court dismissed CAT's earlier-filed suit against MorphoSys on the same patent. Prior to CAT's second filing, MorphoSys filed a suit in a District Court in Washington, DC seeking a declaration of non-infringement and invalidity of the Winter II patent.
``We are very happy with this decision'', stated Dr. Thomas von Rueden, Chief Scientific Officer, MorphoSys AG. ``Our view that there was no basis for CAT to bring this suit in San Diego has been conclusively upheld.'' |
